article New developments in the research field of immuno-oncology 30 April 2021 | By Victoria Rees (Drug Target Review) The exciting potential of immunotherapy for cancer treatment continues its exploration and here, Drug Target Review investigates three of the latest pre-clinical developments in immuno-oncology research.
news Novel cell reprogramming cocktail could advance regenerative medicine 10 March 2020 | By Hannah Balfour (Drug Target Review) Scientists have showed that a three inhibitors (3i) cocktail could reprogramme fibroblasts to a naïve embryonic stem cell-like state and remove disease-associated epigenetic changes.
news Protein vital for breast cancer metastasis discovered 11 September 2019 | By Victoria Rees (Drug Target Review) A research team have identified a protein that binds breast cancer cells together, allowing them to metastasise, which could be significant in the development of cancer therapies.
news ‘Inconsistent’ use of antibodies found in laboratory experiments 16 May 2019 | By Researchers say they have affirmed inconsistencies in the use of a common laboratory procedure called immunohistochemical staining.
news Algorithm used to map cancer resistance to drugs 5 July 2018 | By Drug Target Review New methods of studying the evolution of treatment resistance in head and neck cancer are being developed by researchers at the Johns Hopkins Kimmel Cancer Center...
news Five genetic changes linked to pancreatic cancer risk 27 February 2018 | By Dr Zara Kassam (Drug Target Review) Researchers have discovered changes to five new regions in the human genome that may increase the risk of pancreatic cancer...
news Single blood test screens for eight cancer types 22 January 2018 | By Dr Zara Kassam (Drug Target Review) Researchers have developed a single blood test that screens for eight common cancer types and helps identify the location of cancer...